Joint British Diabetes Society for Inpatient Care (JBDS), UK Chemotherapy Board (UKCB)
This tool provides countless benefits to its users without paying additional money for tools.
Current NICE guidance (NG224) on obesity management and Technology Appraisal 875 for semaglutide recommend considering pharmacological interventions as part of a multicomponent weight management strategy
When you lose weight rapidly, as many women do on GLP-1 medications, this can trigger hormonal fluctuations
Fortunately, there are many natural strategies for endometriosis without all of the negative side effects
Her financial disclosures include Carl Zeiss Meditec, Bausch + Lomb, Viatris, Thea Pharma, Alcon, Allergan, Domp, Balance Ophthalmics, iCare, Tarsus, Orasis, Topcon, Envision Health Technologies and LKC Technologies.